Verition Fund Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $942K | Buy |
51,707
+2,349
| +5% | +$42.8K | ﹤0.01% | 1892 |
|
|
2025
Q1 | $979K | Sell |
49,358
-96,428
| -66% | -$1.91M | ﹤0.01% | 1631 |
|
|
2024
Q4 | $2.5M | Sell |
145,786
-199
| -0.1% | -$3.41K | 0.01% | 1062 |
|
|
2024
Q3 | $2.92M | Buy |
145,985
+134,739
| +1,198% | +$2.69M | 0.01% | 845 |
|
|
2024
Q2 | $126K | Buy |
+11,246
| New | +$126K | ﹤0.01% | 2050 |
|
|
2023
Q3 | – | Sell |
-707,028
| Closed | -$2.61M | – | 1950 |
|
|
2023
Q2 | $2.61M | Buy |
707,028
+393,890
| +126% | +$1.45M | 0.03% | 500 |
|
|
2023
Q1 | $1.04M | Sell |
313,138
-261,920
| -46% | -$867K | 0.01% | 842 |
|
|
2022
Q4 | $2.23M | Sell |
575,058
-794,494
| -58% | -$3.08M | 0.03% | 485 |
|
|
2022
Q3 | $3.33M | Buy |
1,369,552
+1,344,560
| +5,380% | +$3.27M | 0.04% | 529 |
|
|
2022
Q2 | $49K | Sell |
24,992
-1,276,646
| -98% | -$2.5M | ﹤0.01% | 2063 |
|
|
2022
Q1 | $2.38M | Buy |
1,301,638
+797,749
| +158% | +$1.46M | 0.03% | 578 |
|
|
2021
Q4 | $710K | Buy |
+503,889
| New | +$710K | 0.01% | 1050 |
|